Pharmaceutical group

Blueprint

18 medicines5 countries

A group of 5 companies with 18 medicines in 5 countries.

Its medicines

Group structure

5 companies in 1 country

United States1

Blueprint Medicines CorporationAuthorisation holder · 4 medicines

Headquarters not stated4

Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.

Medicines

Every medicine of every company in the group, current ones first.

18 medicines

Medicine	Substance	Country	Status	Authorised
AYVAKIT100mg \| 200mg \| 25mg \| 300mg \| 50mg · Tablet	Avapritinib	United States	Marketed	2020
Ayvakyt	Avapritinib	EU (EMA)	Authorised	2020
AYVAKYT100 mg · Tablet	Avapritinib	Canada	Marketed	2024
AYVAKYT200 mg · Tablet	Avapritinib	Canada	Marketed	2024
AYVAKYT25 mg · Tablet	Avapritinib	Canada	Marketed	2024
AYVAKYT50 mg · Tablet	Avapritinib	Canada	Marketed	2024
AYVAKYT 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA100 mg · Comprimido recubierto con película	Avapritinib	Spain	Marketed	2022
Ayvakyt 100 mg filmomhulde tablettenFilmomhulde tablet	Avapritinib	Netherlands	Authorised	2020
AYVAKYT 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA200 mg · Comprimido recubierto con película	Avapritinib	Spain	Marketed	2022
Ayvakyt 200 mg filmomhulde tablettenFilmomhulde tablet	Avapritinib	Netherlands	Authorised	2020
AYVAKYT 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA25 mg · Comprimido recubierto con película	Avapritinib	Spain	Marketed	2022
Ayvakyt 25 mg filmomhulde tablettenFilmomhulde tablet	Avapritinib	Netherlands	Authorised	2022
AYVAKYT 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA300 mg · Comprimido recubierto con película	Avapritinib	Spain	Marketed	2022
Ayvakyt 300 mg filmomhulde tablettenFilmomhulde tablet	Avapritinib	Netherlands	Authorised	2020
AYVAKYT 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA50 mg · Comprimido recubierto con película	Avapritinib	Spain	Marketed	2022
Ayvakyt 50 mg filmomhulde tablettenFilmomhulde tablet	Avapritinib	Netherlands	Authorised	2022
Gavreto	Pralsetinib	EU (EMA)	Withdrawn	2021
GAVRETO 100 MG CAPSULAS DURAS100 mg · Cápsula dura	Pralsetinib	Spain	Withdrawn	2021

Sources and licences

Country	Medicines	Current	Past	Companies
Spain	6	5	1	Companies All medicines
Netherlands	5	5	0	Companies All medicines
Canada	4	4	0	Companies All medicines
European Union (EMA)	2	1	1	Companies All medicines
United States	1	1	0	Companies All medicines

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.

European Medicines Agency

Source: European Medicines Agency (EPAR data).

Licence: EMA reuse policy (source acknowledgement required)

Agencia Española de Medicamentos y Productos Sanitarios (CIMA)

Fuente de la información: AEMPS (CIMA).

Licence: AEMPS open data reuse with attribution

U.S. Food and Drug Administration (Drugs@FDA, openFDA)

Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.

Licence: Public domain (U.S. Government work)

Base de données publique des médicaments (ANSM, HAS, UNCAM)

Source: BDPM (ANSM, HAS, UNCAM).

Licence: Licence Ouverte v1.0

Health Canada, Canada

Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

All 16 sources

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

BDPM / ANSM, HAS and UNCAM

BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained

Licence: BDPM exact Licence Ouverte v1.0 (October 2011)

BDPM / ANSM, HAS and UNCAM, France

BDPM / ANSM, HAS and UNCAM, CIS_MITM.txt, published 13/10/2026, acquired 2026-10-25T22:15:46.803459+00:00; exact facts retained, no endorsement.

Licence: BDPM exact Licence Ouverte v1.0 (October 2011)

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim

Läkemedelsverket, Sweden

Läkemedelsverket, Sweden, Förvaringstemperatur och hållbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.

Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)

Läkemedelsverket, Sweden

Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.

Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)

Report an error or request removal Corrections from the company itself are welcome.

Blueprint

Group structure

United States1

Headquarters not stated4

Medicines

Know your medicines, with the sources.

Blueprint

Group structure

United States1

Headquarters not stated4

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Work with Prognia

Other big groups

Group structure

🇺🇸United States1

Headquarters not stated4

Medicines

Know your medicines, with the sources.

Group structure

🇺🇸United States1

Headquarters not stated4

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Work with Prognia

United States1

United States1